Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 11566 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Repossi & Cheval Blanc Join Forces to Reimage the Iconic Berbère Ring to Celebrate t... [11906-Views]
Your Autumn/Winter Guide from Essence is Here [10492-Views]
Fall in Love with Catrice [9541-Views]
Eyewear Gift Guide for the Festive Season [6088-Views]
Pandora Launch a New Limited-Edition Charm in Support of UNICEF Giving Young Voices the Ch... [5318-Views]
Samsung Wins 46 CES 2023 Innovation Awards from the Consumer Technology Association [5133-Views]
The Ferrari 125 S, Ferrari's First Car in History Enters the Region for the First Time Eve... [4863-Views]
Ogilvy Celebrates a giant performance at this year's LIA's – Including awards for Global ... [4567-Views]
5 Ways to Style Your Home This Festive Season with West Elm [4547-Views]
TITAN Solar Paves the Way for a Brighter, Sustainable Future [4477-Views]
Panasonic Reaffirms Commitment To Kuwaiti Market as It Extends Partnership With Easa Huss... [3899-Views]
H.E. Sarah Al Amiri Inaugurates Hotpack's AED 250m Plant in NIP [3874-Views]
Opening Day of 22nd Edition of Cityscape Sees Numerous New Developments Showcased inside D... [3231-Views]
New Real Estate Entity to Redefine Buyer Experience with On Time Delivery Assurance [3013-Views]
Dubai Airports makes Parking Payment a Breeze with ‘Scan, Pay and Go' [2854-Views]
Dubai Islamic Bank Successfully Prices USD 750 Million Inaugural Sustainable Sukuk [2763-Views]
The Environment Agency - Abu Dhabi Hosts Youth Debate Around Climate Change [2685-Views]
Shamsuddin PM Demise Note [2653-Views]
Dubai Cares' Enduring Commitment to Promoting Early Childhood Development Receives Global ... [2644-Views]
Paperworld Middle East Highlights Metaverse and Eco-Friendly Innovation Through Dedicated... [2636-Views]
The Face Shop Introduces Vegan Skincare in the UAE [2604-Views]
Arabian Automobiles brings back trade-in offer, this time for the Nissan Patrol [2587-Views]
5th Combined Gulf Cancer Conference to See Stellar Lineup of Policymakers, Scientists, Can... [2567-Views]
MG International Fragrance Company Reinforces Presence in the Growing Middle East Region [2542-Views]
Sita Strengthens its Partnership with Geneva Airport, helping Transform the Passenger Expe... [2538-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories